Although GLP-1RA have been shown to inhibit atherosclerosis in clinical trials such as the previous LEADER study, it is possible that tirzepatide, which has a stronger effect on GIP-R, may exert its anti-atherosclerotic effect through a different mechanism of action than GLP-1RA
van Zon A, Smulders YE, Ramakers GG, et al
In a blog post, Reitano said the company became increasingly aware of patients' challenges with getting access to these new obesity treatments
Pick your protocol and duration we'll show you how many vials you need and the total cost from 3 vendors
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
Both T2DM and hypoglycemic drugs are among the risk factors for acute pancreatitis (77)